XML 85 R74.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation - Additional Information (Details)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Nov. 18, 2020
USD ($)
Grantee
shares
Apr. 22, 2020
USD ($)
Grantee
shares
Jun. 22, 2019
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
TradingDay
shares
Dec. 31, 2024
$ / shares
shares
Feb. 28, 2023
shares
Dec. 31, 2021
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Stock-based compensation | $           $ 37,339,000 $ 21,451,000 $ 66,729,000 $ 50,301,000        
BridgeBio Equity Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Performance-based milestone awards compensation expense | $           100,000 3,600,000 11,800,000        
Stock-based compensation expense, capitalized to inventory | $           1,100,000   $ 1,900,000          
Employee Stock Purchase Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Weighted-average grand date fair value of options granted | $ / shares               $ 11.88          
Expected volatility, Minimum               52.00%          
Expected volatility, Maximum               60.90%          
Risk-free interest rate, Minimum               4.30%          
Risk-free interest rate, Maximum               5.00%          
Dividend yield               0.00%          
Expected term (in years)               6 months          
2020 Stock and Equity Award Exchange Program                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Stock-based compensation cost associated with performance-based milestone awards | $             8,900,000   8,700,000        
Maximum potential milestone performance-based awards to be settled in fully-vested RSA | $ $ 11,700,000 $ 183,400,000                      
Performance-based milestone awards | $ $ 0 $ 17,400,000                      
2020 Stock and Equity Award Exchange Program | Minimum                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Performance-based milestone awards period for recognition   8 months 12 days                      
2020 Stock and Equity Award Exchange Program | Maximum                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Performance-based milestone awards period for recognition   1 year 8 months 12 days                      
Employee Stock Option                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Weighted-average grand date fair value of options granted | $ / shares               $ 30.15          
Expected volatility, Minimum               94.00%          
Expected volatility, Maximum               94.70%          
Dividend yield               0.00%          
Expected term (in years)               6 years          
Employee Stock Option | 2020 Stock and Equity Award Exchange Program                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Number of options issued in exchange of subsidiary equity | shares 70,436 1,268,110                      
Restricted Stock Awards | 2020 Stock and Equity Award Exchange Program                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Stock-based compensation cost associated with performance-based milestone awards | $                 1,600,000        
Number of RSAs issued in exchange of subsidiary equity | shares   50,145                      
Performance based milestone awards compensation expense settled with equity | $           200,000 (1,000,000) $ 400,000 900,000        
Performance-Based RSAs | 2020 Stock and Equity Award Exchange Program                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Number of Performance-Based RSAs issued in exchange of subsidiary equity | shares   22,611                      
Performance-Based Stock Options | 2020 Stock and Equity Award Exchange Program                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Number of Performance-Based stock options issued in exchange of subsidiary equity | shares 10,772                        
A&R 2019 Plan | 2020 Stock and Equity Award Exchange Program                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Number of grantees | Grantee 16 149                      
Number of shares issued in exchange of subsidiary equity | shares 24,924 554,064                      
2021 A&R Plan | Market-Based Restricted Stock Units (RSUs) [Member]                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Stock-based compensation | $           1,000,000 2,400,000 2,000,000 4,800,000        
Unrecognized compensation cost | $       $ 500,000   $ 500,000   $ 500,000          
Unrecognized compensation cost, period for recognition               1 month 6 days          
Grant-date fair value of RSUs | $                   $ 10,800,000      
Expected volatility, Minimum                   96.80%      
Expected volatility, Maximum                   113.70%      
Risk-free interest rate, Minimum                   4.22%      
Risk-free interest rate, Maximum                   4.35%      
Dividend yield                   0.00%      
Unvested shares of restricted stock outstanding | shares       375,000   375,000   375,000          
Weighted average grant date fair value | $ / shares       $ 28.73   $ 28.73   $ 28.73          
2021 A&R Plan | Market-Based Restricted Stock Units (RSUs) [Member] | BridgeBio Equity Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Share-based payment arrangement, consecutive trading days | TradingDay                   20      
2021 A&R Plan | Market-Based Restricted Stock Units (RSUs) [Member] | Minimum                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Expected term (in years)                   3 years      
2021 A&R Plan | Market-Based Restricted Stock Units (RSUs) [Member] | Maximum                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Expected term (in years)                   6 years      
2021 A&R Plan | Market-Based Restricted Stock Units (RSUs) [Member] | Maximum | BridgeBio Equity Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Share-based payment arrangement, performance period from date of grant                   6 years      
2021 A&R Plan | Performance-Based RSUs                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Stock-based compensation | $           $ 700,000   $ 800,000          
Unrecognized compensation cost | $       $ 5,800,000   $ 5,800,000   $ 5,800,000          
Unrecognized compensation cost, period for recognition               2 years 1 month 6 days          
Unvested shares of restricted stock outstanding | shares       194,943   194,943   194,943          
Weighted average grant date fair value | $ / shares       $ 33.75   $ 33.75   $ 33.75          
A&R 2019 Plan and 2019 Inducement Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Total intrinsic value of options exercised | $               $ 8,000,000          
Weighted-average grand date fair value of options granted | $ / shares               $ 30.15          
A&R 2019 Plan and 2019 Inducement Plan | Employee Stock Option                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Stock-based compensation | $           $ 4,200,000 5,900,000 $ 8,600,000 12,200,000        
Unrecognized compensation cost | $       $ 19,000,000   $ 19,000,000   $ 19,000,000          
Unrecognized compensation cost, period for recognition               1 year 7 months 6 days          
A&R 2019 Plan and 2019 Inducement Plan | Employee Stock Option | Minimum                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Vesting period               3 years          
A&R 2019 Plan and 2019 Inducement Plan | Employee Stock Option | Maximum                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Vesting period               4 years          
A&R 2019 Plan and 2019 Inducement Plan | Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs) | Minimum                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Vesting period               2 years          
A&R 2019 Plan and 2019 Inducement Plan | Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs) | Maximum                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Vesting period               4 years          
A&R 2019 Plan and 2019 Inducement Plan | Restricted Stock Units (RSUs)                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Unvested shares of restricted stock outstanding | shares       11,852,773   11,852,773   11,852,773     10,272,798    
Weighted average grant date fair value | $ / shares       $ 26.06   $ 26.06   $ 26.06     $ 21.91    
2019 Employee Stock Purchase Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Common shares reserved for future issuance | shares       3,205,677   3,205,677   3,205,677          
Stock-based compensation | $           $ 700,000 $ 500,000 $ 1,400,000 $ 1,100,000        
Number of common shares authorized to issue for issuance of awards | shares     2,000,000                    
Percentage of automatic annual increase in number of shares reserved for future issuance     1.00%                    
Employees purchased under ESPP, shares | shares               156,097 93,344        
Employees purchased under ESPP | $               $ 3,200,000 $ 2,400,000        
2019 Employee Stock Purchase Plan | BridgeBio Equity Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Purchase price as percentage of lower of fair market value as of beginning or end of offering period     85.00%                    
Maximum percentage of employee payroll deduction for stock purchase     15.00%                    
Maximum number of shares eligible to purchase during offering period | shares     3,500                    
2019 Employee Stock Purchase Plan | Employee Stock Purchase Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Number of common shares authorized to issue for issuance of awards | shares     2,000,000                    
Common Stock | A&R 2019 Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Common shares reserved for future issuance | shares                   3,750,000   2,000,000  
Common Stock | 2021 A&R Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Common shares reserved for future issuance | shares       10,160,349   10,160,349   10,160,349          
Increase (decrease) in common shares reserved for future issuance | shares       5,000,000 6,500,000                
Common Stock | A&R 2019 Inducement Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Common shares reserved for future issuance | shares       891,435   891,435   891,435          
Common Stock | Eidos Award Exchange Plan                          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                          
Common shares reserved for future issuance | shares                         2,802,644